Thomas Helledays Stiftelse for Medicinsk Forskning

Genase Therapeutics B.v.

Lars Sandberg

Martin Haraldsson

Thomas Helleday

Evert Homan

Martin Scobie

Martin Henriksson

Sonia Lain

Ulrika Yngve

Catherine Drummond

Christoffer Bengtsson

Sanjay Borhade

Cynthia Paulin

Pål Stenmark

Karl Vallin

Ingeborg Van Leeuwen

Lars George Johansson

Lars Johansson

A compound of formula I or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound.

2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy

There is herein provided a compound of formula I or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A, A, L, R, Rand n have meanings as provided in the description.

Tetrahydroindazoles and medical uses thereof

A compound of formula (I) or a pharmaceutically acceptable salt thereof. The compound is useful in therapy, e.g. for the treatment of cancers, inflammation, autoimmune diseases and graft-versus host diseases (e.g. in transplantation patients). A pharmaceutical composition comprising the compound or its salt and a method for preparing the compound. 

There is herein provided a compound of formula I (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of cancer and/or the treatment or prevention of a viral infection, wherein A, A, L, R, Rand n have meanings as provided in the description. 

Growing community of inventors

Enskede, Sweden

Lars Sandberg